Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1998 Aug;228(2):194–200. doi: 10.1097/00000658-199808000-00008

The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer.

B M Nakfoor 1, C G Willett 1, P C Shellito 1, D S Kaufman 1, W J Daly 1
PMCID: PMC1191460  PMID: 9712564

Abstract

OBJECTIVE: To analyze the effects of 5-fluorouracil (5-FU) chemotherapy combined with preoperative irradiation and the role of intraoperative electron beam irradiation (IOERT) on the outcome of patients with primary locally advanced rectal or rectosigmoid cancer. METHODS: From 1978 to 1996, 145 patients with locally advanced rectal cancer underwent moderate- to high-dose preoperative irradiation followed by surgical resection. Ninety-three patients received 5-FU as a bolus for 3 days during the first and last weeks of radiation therapy (84 patients) or as a continuous infusion throughout irradiation (9 patients). At surgery, IOERT was administered to the surgical bed of 73 patients with persistent tumor adherence or residual disease in the pelvis. RESULTS: No differences in sphincter preservation, pathologic downstaging, or resectability rates were observed by 5-FU use. However, there were statistically significant improvements in 5-year actuarial local control and disease-specific survival in patients receiving 5-FU during irradiation compared with patients undergoing irradiation without 5-FU. For the 73 patients selected to receive IOERT, local control and disease-specific survival correlated with resection extent. For the 45 patients undergoing complete resection and IOERT, the 5-year actuarial local control and disease-specific survival were 89% and 63%, respectively. These figures were 65% and 32%, respectively, for the 28 patients undergoing IOERT for residual disease. The overall 5-year actuarial complication rate was 11%. CONCLUSIONS: Treatment strategies using 5-FU during irradiation and IOERT for patients with locally advanced rectal cancer are beneficial and well tolerated.

Full text

PDF
194

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dosoretz D. E., Gunderson L. L., Hedberg S., Hoskins B., Blitzer P. H., Shipley W., Cohen A. Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas. Cancer. 1983 Sep 1;52(5):814–818. doi: 10.1002/1097-0142(19830901)52:5<814::aid-cncr2820520511>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  2. Emami B., Pilepich M., Willett C., Munzenrider J. E., Miller H. H. Effect of preoperative irradiation on resectability of colorectal carcinomas. Int J Radiat Oncol Biol Phys. 1982 Aug;8(8):1295–1299. doi: 10.1016/0360-3016(82)90578-8. [DOI] [PubMed] [Google Scholar]
  3. Frykholm G., Glimelius B., Påhlman L. Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primarily non-resectable adenocarcinoma of the rectum. Results from two consecutive studies. Eur J Cancer Clin Oncol. 1989 Nov;25(11):1535–1541. doi: 10.1016/0277-5379(89)90294-0. [DOI] [PubMed] [Google Scholar]
  4. Gunderson L. L., Nelson H., Martenson J. A., Cha S., Haddock M., Devine R., Fieck J. M., Wolff B., Dozois R., O'Connell M. J. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU. Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):601–614. doi: 10.1016/s0360-3016(96)00563-9. [DOI] [PubMed] [Google Scholar]
  5. Landry J. C., Koretz M. J., Wood W. C., Bahri S., Smith R. G., Costa M., Daneker G. W., York M. R., Sarma P. R., Lynn M. Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II study. Radiology. 1993 Aug;188(2):423–426. doi: 10.1148/radiology.188.2.8327689. [DOI] [PubMed] [Google Scholar]
  6. Minsky B. D., Cohen A. M., Kemeny N., Enker W. E., Kelsen D. P., Reichman B., Saltz L., Sigurdson E. R., Frankel J. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol. 1992 Jan;10(1):79–84. doi: 10.1200/JCO.1992.10.1.79. [DOI] [PubMed] [Google Scholar]
  7. Minsky B. D., Cohen A. M., Kemeny N., Enker W. E., Kelsen D. P., Saltz L., Frankel J. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer. 1993 Jun 1;71(11):3486–3492. doi: 10.1002/1097-0142(19930601)71:11<3486::aid-cncr2820711105>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  8. O'Connell M. J., Martenson J. A., Wieand H. S., Krook J. E., Macdonald J. S., Haller D. G., Mayer R. J., Gunderson L. L., Rich T. A. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 1994 Aug 25;331(8):502–507. doi: 10.1056/NEJM199408253310803. [DOI] [PubMed] [Google Scholar]
  9. Weinstein G. D., Rich T. A., Shumate C. R., Skibber J. M., Cleary K. R., Ajani J. A., Ota D. M. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):197–204. doi: 10.1016/0360-3016(94)00481-y. [DOI] [PubMed] [Google Scholar]
  10. Willett C. G., Shellito P. C., Rodkey G. V., Wood W. C. Preoperative irradiation for tethered rectal carcinoma. Radiother Oncol. 1991 Jun;21(2):141–142. doi: 10.1016/0167-8140(91)90087-w. [DOI] [PubMed] [Google Scholar]
  11. Willett C. G., Shellito P. C., Tepper J. E., Eliseo R., Convery K., Wood W. C. Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol. 1991 May;9(5):843–849. doi: 10.1200/JCO.1991.9.5.843. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES